Effect of Fluvoxamine on Cognition, Behavior, Symptoms and mRNA and Protein Expression in Schizophrenia Patients
Status:
Unknown status
Trial end date:
2013-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine effect of Fluvoxamine augmentation on cognitive
function , aggressive behavior , clinical symptoms and mRNA (messenger ribonucleic acid) and
protein expression in human peripheral mononuclear blood cells (PMC) in medicated
schizophrenia patients
Phase:
N/A
Details
Lead Sponsor:
Sha'ar Menashe Mental Health Center Sha’ar Menashe Mental Health Center